학술논문

Plasma fibroblast growth factor 23 is associated with poor outcome and unsuccessful uptitration of guideline-recommended pharmacotherapy in patients with worsening heart failure: 674
Document Type
Academic Journal
Source
European Journal of Heart Failure. May 01, 2016 18 Suppl 1:161-161
Subject
Language
English
ISSN
1388-9842